Int. J. Environ. Res. Public Health 2011, 8(1), 136-147; doi:10.3390/ijerph8010136
Review

Smoking Related Diseases: The Central Role of Monoamine Oxidase

Francine Rendu 1,* email, Katell Peoc’h 2 email, Ivan Berlin 3 email, Daniel Thomas 4 email and Jean-Marie Launay 2 email
1 UMRS 956 (Génétique, Pharmacologie et Physiopathologie des maladies cardiovasculaires), Faculté de Médecine Pitié-Salpétrière, Université Pierre et Marie Curie, 91 Bd de l’hôpital, 75634 Paris cedex 13, France 2 Service de Biochimie et Biologie Moléculaire, Assistance Publique des Hôpitaux de Paris (AP-HP), and Biologie cellulaire, Faculté de Pharmacie, Université Paris-Descartes, Hôpital Lariboisière, 2 rue Ambroise Paré, 75475 Paris cedex 10, France 3 Pharmacologie clinique du tabagisme, Inserm U894, Faculté de Médecine Pitié-Salpétrière, Université Pierre et Marie Curie and Service de pharmacologie, Hôpital Pitié-Salpétrière, 47 Bd de l'Hôpital, 75651 Paris cedex13, France 4 Institut de Cardiologie, Hôpital Pitié-Salpétrière, 47 Bd de l'Hôpital, 75651 Paris cedex13, France
* Author to whom correspondence should be addressed.
Received: 3 December 2010; in revised form: 24 December 2010 / Accepted: 6 January 2011 / Published: 14 January 2011
(This article belongs to the Special Issue Tobacco Smoking: Public Health, Science and Policy)
PDF Full-text Download PDF Full-Text [606 KB, Updated Version, uploaded 17 January 2011 10:46 CET]
The original version is still available [512 KB, uploaded 14 January 2011 15:07 CET]
Abstract: Smoking is a major risk factor of morbidity and mortality. It is well established that monoamine oxidase (MAO) activity is decreased in smokers. Serotonin (5-HT), a major substrate for MAO that circulates as a reserve pool stored in platelets, is a marker of platelet activation. We recently reported that smoking durably modifies the platelet 5-HT/MAO system by inducing a demethylation of the MAO gene promoter resulting in high MAO protein concentration persisting more than ten years after quitting smoking. The present data enlarges the results to another MAO substrate, norepinephrine (NE), further confirming the central role of MAO in tobacco use-induced diseases. Thus, MAO could be a readily accessible and helpful marker in the risk evaluation of smoking-related diseases, from cardiovascular and pulmonary diseases to depression, anxiety and cancer. The present review implements the new finding of epigenetic regulation of MAO and suggests that smoking-induced MAO demethylation can be considered as a hallmark of smoking-related cancers similarly to other aberrant DNA methylations.
Keywords: smoking; serotonin; norepinephrine; monoamine oxidase; cardiovascular; platelets; epigenetic; cancer; depression

Article Statistics

Click here to load and display the download statistics.

Cite This Article

MDPI and ACS Style

Rendu, F.; Peoc’h, K.; Berlin, I.; Thomas, D.; Launay, J.-M. Smoking Related Diseases: The Central Role of Monoamine Oxidase. Int. J. Environ. Res. Public Health 2011, 8, 136-147.

AMA Style

Rendu F, Peoc’h K, Berlin I, Thomas D, Launay J-M. Smoking Related Diseases: The Central Role of Monoamine Oxidase. International Journal of Environmental Research and Public Health. 2011; 8(1):136-147.

Chicago/Turabian Style

Rendu, Francine; Peoc’h, Katell; Berlin, Ivan; Thomas, Daniel; Launay, Jean-Marie. 2011. "Smoking Related Diseases: The Central Role of Monoamine Oxidase." Int. J. Environ. Res. Public Health 8, no. 1: 136-147.

Int. J. Environ. Res. Public Health EISSN 1660-4601 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert